Knowing the scope of meningococcal disease in Latin America

被引:9
作者
Safadi, Marco A. P. [1 ]
Teresa Valenzuela, Maria [2 ]
Carvalho, Ana Flavia [3 ]
De Oliveira, Lucia Helena [4 ]
Salisbury, David M. [5 ]
Andrus, Jon Kim [3 ]
机构
[1] Santa Casa Sao Paulo Sch Med Sci, Sao Paulo, Brazil
[2] Univ Andes, Fac Med, Santiago, Chile
[3] Sabin Vaccine Inst, Washington, DC USA
[4] Pan Amer Hlth Org, Washington, DC USA
[5] Ctr Global Hlth Secur, Chatham House, London, England
来源
REVISTA PANAMERICANA DE SALUD PUBLICA-PAN AMERICAN JOURNAL OF PUBLIC HEALTH | 2017年 / 41卷
关键词
Neisseria meningitidis; meningococcal infections; meningitis; vaccines; public health surveillance; Latin America; CHILE; VACCINE; EPIDEMIOLOGY; PREVENTION; SEROGROUP; CARRIAGE;
D O I
10.26633/RPSP.2017.118
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Opportunities for strengthening surveillance of meningococcal disease exist between and within countries in Latin America. In August of 2015, a workshop was convened in the city of Sao Paulo, Brazil, to address the following objectives: 1) to review meningococcal disease burden and vaccine use in Latin America; 2) to evaluate the effectiveness of current meningococcal surveillance practices in the region; 3) to identify challenges to meningococcal surveillance in the region; and 4) to outline steps for strengthening meningococcal surveillance and disease control in the region. Based on the workshop's discussions, recommendations for strengthening surveillance and controlling meningococcal disease in Latin America focus on improving: a) laboratory capabilities for diagnostic testing; b) communication regarding epidemiologic- and laboratory-based analyses; c) communication during outbreaks; d) monitoring of long-term disease outcomes; e) knowledge of vaccines against serogroup B disease; and f) criteria for defining and controlling meningococcal outbreaks. Overall, improving surveillance will help guide strategies for meningococcal disease prevention and control in Latin America.
引用
收藏
页数:6
相关论文
共 18 条
[1]  
[Anonymous], 2011, Wkly Epidemiol Rec, V86, P521
[2]  
[Anonymous], 2001, Wkly Epidemiol Rec, V76, P282
[3]  
[Anonymous], MEN DIS DIAGN TREATM
[4]   Neisseria meningitidis ST-11 Clonal Complex, Chile, 2012 [J].
Araya, Pamela ;
Fernandez, Jorge ;
Del Canto, Felipe ;
Seoane, Mabel ;
Ibarz-Pavon, Ana B. ;
Barra, Gisselle ;
Pidal, Paola ;
Diaz, Janepsy ;
Hormazabal, Juan C. ;
Valenzuela, Maria T. .
EMERGING INFECTIOUS DISEASES, 2015, 21 (02) :339-341
[5]   Laboratory surveillance for invasive meningococcal disease in Chile, 2006-2012 [J].
Araya, Pamela ;
Diaz, Janepsy ;
Seoane, Mabel ;
Fernandez, Jorge ;
Terrazas, Solana ;
Canals, Andrea ;
Vaquero, Alejandra ;
Barra, Gisselle ;
Hormazabal, Juan C. ;
Pidal, Paola ;
Teresa Valenzuela, M. .
REVISTA CHILENA DE INFECTOLOGIA, 2014, 31 (04) :377-384
[6]  
Center for Disease Control and Prevention, EP PREV VACC PREV DI
[7]  
Cohn AC, 2013, MMWR RECOMM REP, V62, P1
[8]   Prevalence of meningococcal carriage in children and adolescents aged 10-19 years in Chile in 2013 [J].
Diaz, Janepsy ;
Carcamo, Marcela ;
Seoane, Mabel ;
Pidal, Paola ;
Cavada, Gabriel ;
Puentes, Rodrigo ;
Terrazas, Solana ;
Araya, Pamela ;
Ibarz-Pavon, Ana B. ;
Manriquez, Macarena ;
Hormazabal, Juan C. ;
Ayala, Salvador ;
Valenzuela, Maria T. .
JOURNAL OF INFECTION AND PUBLIC HEALTH, 2016, 9 (04) :506-515
[9]  
Harrison Lee H, 2011, Vaccine, V29, P3363, DOI 10.1016/j.vaccine.2011.02.058
[10]   Meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine: a new conjugate vaccine against invasive meningococcal disease [J].
Hedari, Carine P. ;
Khinkarly, Rima W. ;
Dbaibo, Ghassan S. .
INFECTION AND DRUG RESISTANCE, 2014, 7 :85-99